CTI is global organization with associates in more than 65 countries across the world. We have worked on more than 10,000 projects and have contributed to more than 150 new drug and device approvals through global regulatory agencies such as the FDA, EMA, and others. Currently, we work with approximately 250 pharmaceutical and emerging biotechnology and medical device companies.Staying true to our roots, we focus on chronically and critically ill patient populations namely in… Show more CTI is global organization with associates in more than 65 countries across the world. We have worked on more than 10,000 projects and have contributed to more than 150 new drug and device approvals through global regulatory agencies such as the FDA, EMA, and others. Currently, we work with approximately 250 pharmaceutical and emerging biotechnology and medical device companies.Staying true to our roots, we focus on chronically and critically ill patient populations namely in regenerative medicine, cell and gene therapies, immuno-suppression and oncology. CTI is a leader in rare and orphan disease research with approximately 80% of our work falling into this category. This focus, an active leadership team, careful hiring practices, a robust internal training program, and a consistent annual retention rate of 90% have all combined to enable the development of an expert workforce whose deep knowledge and experience differentiates our team from those of other service providers. We believe cures for debilitating diseases and prevention of catastrophic illnesses are possible in the next 10 to 15 years with advances in fields such as regenerative medicine and personalized therapies, and we are privileged to be in a leadership role for these exciting and life-changing projects. Show less

Consulting services in:- Research and Development for Pharmaceutical, Biotechnology and Medical Devices industries.- Business Development - Clinical Outcome Assessments (COA/PRO) strategies, instruments and implementation- Cardiac Safety strategies and solutions- Respiratory Solutions in Clinical Trials

Eurotrials was acquired by CTI in November 2017.Head of International Business Development - USA, Europe and IsraelEurotrials is a European full-service CRO, with more than 20 years of experience, focused in the European and Latin American markets, with strong local expertise. Our services cover all the steps of clinical, translational and epidemiological research, from the initial research question to the final output.Eurotrials provides an extensive array of services from… Show more Eurotrials was acquired by CTI in November 2017.Head of International Business Development - USA, Europe and IsraelEurotrials is a European full-service CRO, with more than 20 years of experience, focused in the European and Latin American markets, with strong local expertise. Our services cover all the steps of clinical, translational and epidemiological research, from the initial research question to the final output.Eurotrials provides an extensive array of services from early- to late-stage research as well as product support in accordance with global and specific regional requirements. Innovative models of collaboration with the biopharmaceutical and device industry, research institutions and clinical research sites are the main drivers of Eurotrials’ development strategy. Show less

Senior Business Development consultant for South Europe and Israel. iCardiac Technologies is an innovative core laboratory for cardiac safety and respiratory services that has introduced several breakthrough innovations to the cardiac safety industry, including the High Precision QT and Early Precision QT methodologies. iCardiac’s is an active contributor on several FDA working groups that are advancing the field of drug safety.

Senior Director, Business Development responsible for France, Switzerland, Italy, Portugal, Israel and some accounts in the UK and Germany across all ERT business areas:- Clinical Outcome Assessments (COA)- Cardiac Safety- Respiratory Solutions- Suicide Risk Assessment- Insights Cloud, including Data Integration and Access, Analytics and Workflow.ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in… Show more Senior Director, Business Development responsible for France, Switzerland, Italy, Portugal, Israel and some accounts in the UK and Germany across all ERT business areas:- Clinical Outcome Assessments (COA)- Cardiac Safety- Respiratory Solutions- Suicide Risk Assessment- Insights Cloud, including Data Integration and Access, Analytics and Workflow.ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicidal risk assessment and Clinical Outcome Assessments (COA) – which includes patient, clinician, and observer reported outcomes. ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. Show less

ERT Consulting representative in Europe, for consulting services in Clinical Outcome Assessments (COAs) and Cardiac Safety.Experienced in HEOR and Market Access with relevant contacts in Europe.ERT consulting group provides expertise to biopharmaceutical companies when making decisions about the strategies, instruments, implementation, and regulatory defense of Clinical Outcome Assessments (COAs) in clinical programs. ERT scientific experts are thought leaders in the industry and… Show more ERT Consulting representative in Europe, for consulting services in Clinical Outcome Assessments (COAs) and Cardiac Safety.Experienced in HEOR and Market Access with relevant contacts in Europe.ERT consulting group provides expertise to biopharmaceutical companies when making decisions about the strategies, instruments, implementation, and regulatory defense of Clinical Outcome Assessments (COAs) in clinical programs. ERT scientific experts are thought leaders in the industry and support the decision making in the creation, execution and documentation of a COA strategy to support the specific objectives, complexity, patient population and geographic coverage of research programs. The team also assists our clients in interpreting and applying regulatory guidance, as well as packaging evidence to support regulatory advice meetings and submissions. Show less

Business Administration, International Business Development, Proposals and Contracts Management, Marketing and Vendor Selection & Management.The CRO Eurotrials has Operations in Europe and Latin America.

Head of Data Management and IT in the CRO Eurotrials, responsible for Data Management and IT teams coordination.During this period, alongside with the normal projects Data Management operations, the company migrated between Clinical Data Management Systems, implemented an EDC system and assumed 21 CFR part 11 compliance and CDISC standards use.

Head of Business Development and Contracts, responsible for Business Development, Contracts and Proposals teams, Marketing and Vendor Selection & Management.Eurotrials has Operations in Europe and Latin America.

Quality and ISO 9001 Auditor responsible for internal and external quality audits and ISO 9001 audits.Data Management Quality Controller.

Project Manager in Phase II and III Clinical Trials in Psychiatry, Endocrinology, Gynecology, Pneumology, ENT and Infectious Diseases.

Experience as a Clinical Research Associate in Phase II and III Clinical Trials in Oncology, Cardiology, Neurology, Rheumatology, ENT, Orthopedics, Pneumology, Ophthalmology and Psychiatry.